- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- February 2025
- 221 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- August 2024
- 178 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- July 2024
- 139 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 225 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 184 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 184 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- January 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 106 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 70 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 70 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- May 2024
- 145 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- December 2024
- 144 Pages
Global
From €13648EUR$14,995USD£11,592GBP
- Report
- November 2024
- 69 Pages
Global
From €3636EUR$3,995USD£3,088GBP
- Report
- May 2024
- 93 Pages
Global
From €13648EUR$14,995USD£11,592GBP
- Report
- August 2024
- 268 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- October 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- June 2024
- 218 Pages
Global
From €4546EUR$4,995USD£3,861GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more